sr141716 has been researched along with glucagon-like peptide 1 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; McCorvy, JD; Tan, L; Yan, W | 1 |
| Cani, PD; Delzenne, NM; Lambert, DM; Montoya, ML; Neyrinck, AM | 1 |
| Klein, HH; Meier, JJ; Schmidt, WE | 1 |
| Alemany, M; Cabot, C; Fernández-López, JA; Ferrer-Lorente, R | 1 |
| Harrison, SA; Kashi, MR; Torres, DM | 1 |
| Galzin, AM; Guillot, E; Jelsing, J; Larsen, PJ; Pruniaux, MP; Vrang, N | 1 |
| Atkin, SL; Cho, L; Coady, AM; Kilpatrick, ES; Le Roux, CW; Sathyapalan, T | 1 |
| Bedros, JR; Medvegy, M; Pados, G; Simonyi, G | 1 |
| Bahekar, R; Jain, MR; Joharapurkar, AA; Kshirsagar, SG; Patel, KN; Patel, V; Srivastava, BK | 1 |
| Brissard, L; Degrace, P; Demizieux, L; Hichami, A; Khan, NA; Leemput, J; Maquart, G; Passilly-Degrace, P | 1 |
| Breault, DT; Carlone, DL; de Sousa Casal, J; Dubois, S; Hafner, S; Karp, JM; Mannam, P; Ordovas-Montanes, J; Qi, W; Shah, MS; Stas, E; Syverson, EP; Yin, X; Zeve, D | 1 |
4 review(s) available for sr141716 and glucagon-like peptide 1
| Article | Year |
|---|---|
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship | 2018 |
[New concepts in the treatment of type 2 diabetes].
Topics: Adamantane; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Liraglutide; Nitriles; Peptides; Piperidines; Pyrazines; Pyrazoles; Pyrrolidines; Rimonabant; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin | 2007 |
Current and emerging therapies in nonalcoholic fatty liver disease.
Topics: Animals; Antioxidants; Bariatric Surgery; Body Mass Index; Cannabinoids; Cholagogues and Choleretics; Comorbidity; Fatty Liver; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin Resistance; Lactones; Life Style; Metformin; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Thiazolidinediones; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss | 2008 |
[The pharmacological treatment of obesity: past, present and future].
Topics: Amides; Anti-Obesity Agents; Anticonvulsants; Antidepressive Agents; Basal Metabolism; Benzazepines; Benzoxazines; Body Mass Index; Bridged Bicyclo Compounds, Heterocyclic; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Fatty Acids; Female; Fenfluramine; Glucagon-Like Peptide 1; Human Growth Hormone; Humans; Intestinal Absorption; Lactones; Leptin; Life Style; Liraglutide; Male; Norepinephrine; Obesity; Obesity, Morbid; Orlistat; Piperidines; Pyrazoles; Pyridines; Receptor, Melanocortin, Type 4; Rimonabant; Satiation; Serotonin; Sodium-Glucose Transport Proteins; Sucrose; Thyroid Hormones | 2012 |
1 trial(s) available for sr141716 and glucagon-like peptide 1
| Article | Year |
|---|---|
Effect of rimonabant and metformin on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in obese women with polycystic ovary syndrome.
Topics: Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Metformin; Obesity; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant | 2010 |
6 other study(ies) available for sr141716 and glucagon-like peptide 1
| Article | Year |
|---|---|
Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
Topics: Animals; Appetite Regulation; Blood Glucose; Blotting, Western; Cannabinoids; Eating; Endocannabinoids; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Male; Oleic Acids; Peptide Fragments; Peptide Hormones; Piperidines; Protein Precursors; Pyrazoles; Rats; Rats, Wistar; Receptors, Drug; Rimonabant | 2004 |
Effects of combined oleoyl-estrone and rimonabant on overweight rats.
Topics: Animals; Anti-Obesity Agents; Appetite; Blood Glucose; Cholecystokinin; Cholesterol; Drug Synergism; Drug Therapy, Combination; Eating; Energy Metabolism; Estrone; Fatty Acids, Nonesterified; Ghrelin; Glucagon-Like Peptide 1; Insulin; Leptin; Male; Obesity; Oleic Acids; Overweight; Peptide Hormones; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; Triglycerides | 2007 |
Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2.
Topics: Amygdala; Animals; Arcuate Nucleus of Hypothalamus; Benzoxazines; Brain Stem; Corpus Striatum; Glucagon-Like Peptide 1; Hypothalamus; Immunohistochemistry; Injections, Intraperitoneal; Male; Morpholines; Naphthalenes; Neurons; Paraventricular Hypothalamic Nucleus; Piperidines; Prosencephalon; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Solitary Nucleus; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Diet, High-Fat; Drug Synergism; Eating; Exenatide; Glucagon; Glucagon-Like Peptide 1; Insulin Resistance; Male; Mice, Inbred C57BL; Mice, Obese; Obesity; Peptides; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Venoms | 2014 |
Orosensory Detection of Dietary Fatty Acids Is Altered in CB₁R
Topics: Animals; Calcium Signaling; Cannabinoid Receptor Antagonists; CD36 Antigens; Dietary Fats; Fatty Acids; Food Preferences; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Linoleic Acid; Male; Mice, Knockout; Obesity; Proglucagon; Rapeseed Oil; Receptor, Cannabinoid, CB1; Receptors, G-Protein-Coupled; Rimonabant; RNA, Messenger; Taste; Taste Buds; Taste Perception | 2018 |
Robust differentiation of human enteroendocrine cells from intestinal stem cells.
Topics: Anthracenes; Cell Differentiation; Chromogranin A; Endocannabinoids; Enteroendocrine Cells; Glucagon-Like Peptide 1; Humans; Intestinal Mucosa; Peptide YY; Quinolones; Rimonabant; Signal Transduction; Somatostatin; Stem Cells; Transcription Factors | 2022 |